Phenotypic spectrum of serious cutaneous only adverse event following immunisation with COVID-19 vaccines: a multi-centre case series and literature review.

A phenotypic plethora of exclusively cutaneous adverse events following immunisation (AEFI) with COVID-19 vaccines have been described. Currently, there is no formal consensus on advice given to affected individuals, pertaining to their subsequent COVID-19 vaccines, which is increasingly pertinent as countries such as the United Kingdom launch a further booster phase of the COVID-19 mass vaccination program due to concerns over waning immunity from initial vaccinations.